335 related articles for article (PubMed ID: 21764184)
41. Thienopyrimidines as novel inhibitors of Mycobacterium tuberculosis: synthesis and in-vitro studies.
Rashmi P; Nargund LV; Hazra K; Chandra JN
Arch Pharm (Weinheim); 2011 Jul; 344(7):459-65. PubMed ID: 21598298
[TBL] [Abstract][Full Text] [Related]
42. Antituberculosis agents IV: in vitro antimycobacterial activity and cytotoxicity of N-piperazinyl quinolone derivatives containing 2-thienyl and 2-furyl moiety.
Foroumadi A; Soltani F; Mirzaei M
Pharmazie; 2003 May; 58(5):347-8. PubMed ID: 12779054
[TBL] [Abstract][Full Text] [Related]
43. Novel pyrazine analogs of chalcones: synthesis and evaluation of their antifungal and antimycobacterial activity.
Kucerova-Chlupacova M; Kunes J; Buchta V; Vejsova M; Opletalova V
Molecules; 2015 Jan; 20(1):1104-17. PubMed ID: 25587786
[TBL] [Abstract][Full Text] [Related]
44. Design, synthesis, and biological evaluation of 4-(5-nitrofuran-2-yl)prop-2-en-1-one derivatives as potent antitubercular agents.
Tawari NR; Bairwa R; Ray MK; Rajan MG; Degani MS
Bioorg Med Chem Lett; 2010 Nov; 20(21):6175-8. PubMed ID: 20850299
[TBL] [Abstract][Full Text] [Related]
45. Discovery of novel bis-oxazolidinone compounds as potential potent and selective antitubercular agents.
Ang W; Ye W; Sang Z; Liu Y; Yang T; Deng Y; Luo Y; Wei Y
Bioorg Med Chem Lett; 2014 Mar; 24(6):1496-501. PubMed ID: 24582981
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of Mycobacterium tuberculosis tyrosine phosphatase PtpA by synthetic chalcones: kinetics, molecular modeling, toxicity and effect on growth.
Mascarello A; Chiaradia LD; Vernal J; Villarino A; Guido RV; Perizzolo P; Poirier V; Wong D; Martins PG; Nunes RJ; Yunes RA; Andricopulo AD; Av-Gay Y; Terenzi H
Bioorg Med Chem; 2010 Jun; 18(11):3783-9. PubMed ID: 20462762
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and evaluation of novel monosubstituted sulfonylurea derivatives as antituberculosis agents.
Pan L; Jiang Y; Liu Z; Liu XH; Liu Z; Wang G; Li ZM; Wang D
Eur J Med Chem; 2012 Apr; 50():18-26. PubMed ID: 22326144
[TBL] [Abstract][Full Text] [Related]
48. C-3 alkyl/arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: synthesis, biological evaluation, and QSAR study.
Saquib M; Gupta MK; Sagar R; Prabhakar YS; Shaw AK; Kumar R; Maulik PR; Gaikwad AN; Sinha S; Srivastava AK; Chaturvedi V; Srivastava R; Srivastava BS
J Med Chem; 2007 Jun; 50(13):2942-50. PubMed ID: 17542574
[TBL] [Abstract][Full Text] [Related]
49. Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents.
Kumar G; Siva Krishna V; Sriram D; Jachak SM
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000077. PubMed ID: 32484273
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and evaluation of chromenyl barbiturates and thiobarbiturates as potential antitubercular agents.
Vijaya Laxmi S; Thirupathi Reddy Y; Suresh Kuarm B; Narsimha Reddy P; Crooks PA; Rajitha B
Bioorg Med Chem Lett; 2011 Jul; 21(14):4329-31. PubMed ID: 21684158
[TBL] [Abstract][Full Text] [Related]
51. Discovery of novel antitubercular 2,10-dihydro-4aH-chromeno[3,2-c]pyridin-3-yl derivatives.
Sriram D; Yogeeswari P; Dinakaran M; Banerjee D; Bhat P; Gadhwal S
Eur J Med Chem; 2010 Jan; 45(1):120-3. PubMed ID: 19942326
[TBL] [Abstract][Full Text] [Related]
52. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
54. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.
Braendvang M; Bakken V; Gundersen LL
Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890
[TBL] [Abstract][Full Text] [Related]
55. Antimycobacterial terpenoids from Juniperus communis L. (Cuppressaceae).
Gordien AY; Gray AI; Franzblau SG; Seidel V
J Ethnopharmacol; 2009 Dec; 126(3):500-5. PubMed ID: 19755141
[TBL] [Abstract][Full Text] [Related]
56. 1-Chloro-2-formyl indenes and tetralenes as antitubercular agents.
Chanda D; Saikia D; Kumar JK; Thakur JP; Agarwal J; Chanotiya CS; Shanker K; Negi AS
Bioorg Med Chem Lett; 2011 Jul; 21(13):3966-9. PubMed ID: 21641212
[TBL] [Abstract][Full Text] [Related]
57. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
Abdel-Rahman HM; El-Koussi NA; Hassan HY
Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
[TBL] [Abstract][Full Text] [Related]
58. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
[TBL] [Abstract][Full Text] [Related]
59. Synthesis of novel isothiazolopyridines and their in vitro evaluation against Mycobacterium and Propionibacterium acnes.
Malinka W; Swiątek P; Sliwińska M; Szponar B; Gamian A; Karczmarzyk Z; Fruziński A
Bioorg Med Chem; 2013 Sep; 21(17):5282-91. PubMed ID: 23850103
[TBL] [Abstract][Full Text] [Related]
60. Structural requirements for the antitubercular quaternized triflupromazine pharmacophore.
Kunciw DL; Liechty JJ; Mitchell MO; Wan B; Franzblau SG
Bioorg Med Chem Lett; 2012 Sep; 22(17):5679-80. PubMed ID: 22850215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
